Fresenius Medical Care AquaA, Instructions For Use Manual

Page: 19 / 240

Chapter 2: Important information
Fresenius Medical Care AquaA IFU-EN-US 06B-2021 19
– Acute urticaria
– Anxiety
– Impaired quality of life
– Clotting
– Blood loss
– Depressive symptoms
– Dialysis disequilibrium syndrome
– Thirst
– Vomiting
– Fever
– Hemolysis
– Hypotension
– Itching
– Cardiac arrhythmia
– Headache
– Seizures
– Cramps
– Micro air embolisms
– Cardiac tamponade
– Reactions to the dialyzer
– Sleep disturbance
– Pain (chest and back)
– Shivering
– Falls
– Nausea
– Restlessness
2.8 Contraindications
As permeate or dialysis water is never used directly on patients, there
are no known contraindications. However, there are certain
contraindications when used in the context of hemodialysis treatment:
– Hyperkalemia (only with potassium-containing hemodialysis
concentrates)
– Hypokalemia (only with potassium-free hemodialysis concentrates)
– Uncontrollable blood-clotting disorders
Relative contraindications (predictors for poor treatment
outcome/treatment decision on an individual basis):
– Hypotensive heart failure
– Malignant disease with poor prognosis
– Severe peripheral arterial disease (no access possible)
– Severe mental illness to the extent that patient is not aware of
treatment and cannot comply.
A different method of extracorporeal treatment may be indicated for
hemodynamically unstable patients.